{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:09:13Z","timestamp":1785521353811,"version":"3.56.0"},"reference-count":82,"publisher":"Oxford University Press (OUP)","issue":"25","license":[{"start":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T00:00:00Z","timestamp":1574899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P20 GM103492"],"award-info":[{"award-number":["P20 GM103492"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 HL078825"],"award-info":[{"award-number":["P01 HL078825"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 HL113530"],"award-info":[{"award-number":["UM1 HL113530"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL141191"],"award-info":[{"award-number":["R01 HL141191"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Despite the well-documented capacity of embryonic stem cells (ESCs) to differentiate into cardiomyocytes, transplantation of ESCs or ESC-derived cells is plagued by several formidable problems, including graft rejection, arrhythmias, and potential risk of teratomas. Life-long immunosuppression is a disease in itself. Transplantation of human ESC-derived cells in primates causes life-threatening arrhythmias, and the doses used to show efficacy are not clinically relevant. In contemporary clinical research, the margin of tolerance for such catastrophic effects as malignancies is zero, and although the probability of tumours can be reduced by ESC differentiation, it is unlikely to be completely eliminated, particularly when billions of cells are injected. Although ESCs and ESC-derived cells were touted as capable of long-term regeneration, these cells disappear rapidly after transplantation and there is no evidence of long-term engraftment, let alone regeneration. There is, however, mounting evidence that they act via paracrine mechanisms\u2014just like adult cells. To date, no controlled clinical trial of ESC-derived cells in cardiovascular disease has been conducted or even initiated. In contrast, adult cells have been used in thousands of patients with heart disease, with no significant adverse effects and with results that were sufficiently encouraging to warrant Phase II and III trials. Furthermore, induced pluripotent stem cells offer pluripotency similar to ESCs without the need for lifelong immunosuppression. After two decades, the promise that ESC-derived cells would regenerate dead myocardium has not been fulfilled. The most reasonable interpretation of current data is that ESC-based therapies are not likely to have clinical application for heart disease.<\/jats:p>","DOI":"10.1093\/eurheartj\/ehz787","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T19:25:31Z","timestamp":1572031531000},"page":"2397-2404","source":"Crossref","is-referenced-by-count":37,"title":["A realistic appraisal of the use of embryonic stem cell-based therapies for cardiac repair"],"prefix":"10.1093","volume":"41","author":[{"given":"Marcin","family":"Wysoczynski","sequence":"first","affiliation":[{"name":"Department of Medicine, Institute of Molecular Cardiology, University of Louisville , Louisville, KY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9160-8614","authenticated-orcid":false,"given":"Roberto","family":"Bolli","sequence":"additional","affiliation":[{"name":"Department of Medicine, Institute of Molecular Cardiology, University of Louisville , Louisville, KY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,11,28]]},"reference":[{"key":"2022102611022185300_ehz787-B1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.stem.2019.06.010","article-title":"Defining human pluripotency","volume":"25","author":"Yilmaz","year":"2019","journal-title":"Cell Stem Cell"},{"key":"2022102611022185300_ehz787-B2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature15515","article-title":"Hallmarks of pluripotency","volume":"525","author":"De Los Angeles","year":"2015","journal-title":"Nature"},{"key":"2022102611022185300_ehz787-B3","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMra1716145","article-title":"Stem cells in the treatment of disease","volume":"380","year":"2019","journal-title":"N Engl J Med"},{"key":"2022102611022185300_ehz787-B4","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nrm.2016.10","article-title":"Pluripotent stem cells progressing to the clinic","volume":"17","author":"Trounson","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2022102611022185300_ehz787-B5","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCRESAHA.118.313251","article-title":"New paradigms in cell therapy: repeated dosing, intravenous delivery, immunomodulatory actions, and new cell types","volume":"123","author":"Wysoczynski","year":"2018","journal-title":"Circ Res"},{"key":"2022102611022185300_ehz787-B6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/CIRCRESAHA.118.311217","article-title":"Clinical studies of cell therapy in cardiovascular medicine: recent developments and future directions","volume":"123","author":"Banerjee","year":"2018","journal-title":"Circ Res"},{"key":"2022102611022185300_ehz787-B7","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/CIRCULATIONAHA.105.613034","article-title":"Cell therapy for acute myocardial infarction: curb your enthusiasm?","volume":"113","author":"Welt","year":"2006","journal-title":"Circulation"},{"key":"2022102611022185300_ehz787-B8","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/ndt\/gfh140","article-title":"Stem cell therapy of cardiac disease: an update","volume":"19","author":"Honold","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"2022102611022185300_ehz787-B9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1053\/j.semtcvs.2005.09.004","article-title":"Cell therapy for heart failure\u2013muscle, bone marrow, blood, and cardiac-derived stem cells","volume":"17","author":"Ott","year":"2005","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"2022102611022185300_ehz787-B10","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nature02446","article-title":"Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts","volume":"428","author":"Murry","year":"2004","journal-title":"Nature"},{"key":"2022102611022185300_ehz787-B11","doi-asserted-by":"crossref","first-page":"18.","DOI":"10.1007\/s00395-017-0606-5","article-title":"Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction","volume":"112","author":"Guo","year":"2017","journal-title":"Basic Res Cardiol"},{"key":"2022102611022185300_ehz787-B12","doi-asserted-by":"crossref","first-page":"e96725.","DOI":"10.1371\/journal.pone.0096725","article-title":"c-kit+ Cardiac stem cells alleviate post-myocardial infarction left ventricular dysfunction despite poor engraftment and negligible retention in the recipient heart","volume":"9","author":"Hong","year":"2014","journal-title":"PLoS One"},{"key":"2022102611022185300_ehz787-B13","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCRESAHA.116.308937","article-title":"Repeated administrations of cardiac progenitor cells are markedly more effective than a single administration: a new paradigm in cell therapy","volume":"119","author":"Tokita","year":"2016","journal-title":"Circ Res"},{"key":"2022102611022185300_ehz787-B14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fcell.2016.00078","article-title":"A new method to stabilize C-kit expression in reparative cardiac mesenchymal cells","volume":"4","author":"Wysoczynski","year":"2016","journal-title":"Front Cell Dev Biol"},{"key":"2022102611022185300_ehz787-B15","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/CIRCRESAHA.117.311174","article-title":"Cortical bone stem cell therapy preserves cardiac structure and function after myocardial infarction","volume":"121","author":"Sharp","year":"2017","journal-title":"Circ Res"},{"key":"2022102611022185300_ehz787-B16","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.jacc.2017.01.048","article-title":"Myocardial reparative properties of cardiac mesenchymal cells isolated on the basis of adherence","volume":"69","author":"Wysoczynski","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2022102611022185300_ehz787-B17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1161\/CIRCULATIONAHA.112.131110","article-title":"Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction","volume":"127","author":"Williams","year":"2013","journal-title":"Circulation"},{"key":"2022102611022185300_ehz787-B18","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/CIRCRESAHA.113.300219","article-title":"Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions","volume":"113","author":"Sanganalmath","year":"2013","journal-title":"Circ Res"},{"key":"2022102611022185300_ehz787-B19","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1161\/CIRCRESAHA.116.305557","article-title":"\u201cString theory\u201d of c-kit(pos) cardiac cells: a new paradigm regarding the nature of these cells that may reconcile apparently discrepant results","volume":"116","author":"Keith","year":"2015","journal-title":"Circ Res"},{"key":"2022102611022185300_ehz787-B20","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/j.jacc.2015.09.002","article-title":"Cell therapy needs rigorous translational studies in large animal models","volume":"66","author":"Bolli","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2022102611022185300_ehz787-B21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nrcardio.2017.38","article-title":"Stem cells: cell therapy for cardiac repair: what is needed to move forward?","volume":"14","author":"Bolli","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2022102611022185300_ehz787-B22","doi-asserted-by":"crossref","first-page":"15014.","DOI":"10.1038\/srep15014","article-title":"Directed differentiation of embryonic stem cells into cardiomyocytes by bacterial injection of defined transcription factors","volume":"5","author":"Bai","year":"2015","journal-title":"Sci Rep"},{"key":"2022102611022185300_ehz787-B23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/01.RES.0000027865.61704.32","article-title":"Differentiation of pluripotent embryonic stem cells into cardiomyocytes","volume":"91","author":"Boheler","year":"2002","journal-title":"Circ Res"},{"key":"2022102611022185300_ehz787-B24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1172\/JCI200112131","article-title":"Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes","volume":"108","author":"Kehat","year":"2001","journal-title":"J Clin Invest"},{"key":"2022102611022185300_ehz787-B25","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/nbt1014","article-title":"Electromechanical integration of cardiomyocytes derived from human embryonic stem cells","volume":"22","author":"Kehat","year":"2004","journal-title":"Nat Biotechnol"},{"key":"2022102611022185300_ehz787-B26","doi-asserted-by":"crossref","DOI":"10.1002\/9780470151808.sc01f02s2","article-title":"Differentiation of human embryonic stem cells to cardiomyocytes by coculture with endoderm in serum-free medium","author":"Mummery","year":"2007","journal-title":"Curr Protoc Stem Cell Biol"},{"key":"2022102611022185300_ehz787-B27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/CIRCRESAHA.110.227512","article-title":"Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview","volume":"111","author":"Mummery","year":"2012","journal-title":"Circ Res"},{"key":"2022102611022185300_ehz787-B28","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1161\/01.RES.0000035254.80718.91","article-title":"Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells","volume":"91","author":"Xu","year":"2002","journal-title":"Circ Res"},{"key":"2022102611022185300_ehz787-B29","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.healun.2014.10.008","article-title":"Long-term functional benefits of human embryonic stem cell-derived cardiac progenitors embedded into a fibrin scaffold","volume":"34","author":"Bellamy","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"2022102611022185300_ehz787-B30","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI40120","article-title":"A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates","volume":"120","author":"Blin","year":"2010","journal-title":"J Clin Invest"},{"key":"2022102611022185300_ehz787-B31","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1161\/CIRCRESAHA.117.310803","article-title":"Paracrine effects of the pluripotent stem cell-derived cardiac myocytes salvage the injured myocardium","volume":"121","author":"Tachibana","year":"2017","journal-title":"Circ Res"},{"key":"2022102611022185300_ehz787-B32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.scr.2007.06.001","article-title":"Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction","volume":"1","author":"van Laake","year":"2007","journal-title":"Stem Cell Res"},{"key":"2022102611022185300_ehz787-B33","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.yjmcc.2010.09.008","article-title":"Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats","volume":"49","author":"Fernandes","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"2022102611022185300_ehz787-B34","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nbt.4162","article-title":"Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates","volume":"36","author":"Liu","year":"2018","journal-title":"Nat Biotechnol"},{"key":"2022102611022185300_ehz787-B35","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nature11317","article-title":"Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts","volume":"489","author":"Shiba","year":"2012","journal-title":"Nature"},{"key":"2022102611022185300_ehz787-B36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nature13233","article-title":"Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts","volume":"510","author":"Chong","year":"2014","journal-title":"Nature"},{"key":"2022102611022185300_ehz787-B37","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"key":"2022102611022185300_ehz787-B38","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMp048045","article-title":"New human embryonic stem-cell lines\u2014more is better","volume":"350","author":"Gearhart","year":"2004","journal-title":"N Engl J Med"},{"key":"2022102611022185300_ehz787-B39","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1056\/NEJMp048200","article-title":"Missed opportunities in embryonic stem-cell research","volume":"351","author":"Daley","year":"2004","journal-title":"N Engl J Med"},{"key":"2022102611022185300_ehz787-B40","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJMp068206","article-title":"Stem-cell politics","volume":"355","author":"Okie","year":"2006","journal-title":"N Engl J Med"},{"key":"2022102611022185300_ehz787-B41","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMp068180","article-title":"The politics and promise of stem-cell research","volume":"355","author":"Schwartz","year":"2006","journal-title":"N Engl J Med"},{"key":"2022102611022185300_ehz787-B42","doi-asserted-by":"crossref","first-page":"e48.","DOI":"10.1056\/NEJMp1105088","article-title":"Human embryonic stem-cell research under siege\u2013battle won but not the war","volume":"364","author":"Cohen","year":"2011","journal-title":"N Engl J Med"},{"key":"2022102611022185300_ehz787-B43","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.scr.2014.06.005","article-title":"Cardiac regeneration using pluripotent stem cells\u2013progression to large animal models","volume":"13","author":"Chong","year":"2014","journal-title":"Stem Cell Res"},{"key":"2022102611022185300_ehz787-B44","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jacc.2017.11.042","article-title":"Trial of embryonic stem cell-derived cardiac progenitor cells: an encouraging start","volume":"71","author":"Miller","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2022102611022185300_ehz787-B45","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCRESAHA.119.314869","article-title":"Human embryonic stem cell-derived cardiomyocytes","volume":"124","author":"Bolli","year":"2019","journal-title":"Circ Res"},{"key":"2022102611022185300_ehz787-B46","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.111.087684","article-title":"Transplantation and tracking of human-induced pluripotent stem cells in a pig model of myocardial infarction: assessment of cell survival, engraftment, and distribution by hybrid single photon emission computed tomography\/computed tomography of sodium iodide symporter transgene expression","volume":"126","author":"Templin","year":"2012","journal-title":"Circulation"},{"key":"2022102611022185300_ehz787-B47","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1161\/CIRCRESAHA.117.311578","article-title":"Lack of remuscularization following transplantation of human embryonic stem cell-derived cardiovascular progenitor cells in infarcted nonhuman primates","volume":"122","author":"Zhu","year":"2018","journal-title":"Circ Res"},{"key":"2022102611022185300_ehz787-B48","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/eurheartj\/ehv189","article-title":"Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report","volume":"36","author":"Menasche","year":"2015","journal-title":"Eur Heart J"},{"key":"2022102611022185300_ehz787-B49","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jacc.2017.11.047","article-title":"Transplantation of human embryonic stem cell-derived cardiovascular progenitors for severe ischemic left ventricular dysfunction","volume":"71","author":"Menasche","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2022102611022185300_ehz787-B50","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.healun.2016.01.013","article-title":"Cardiovascular progenitor-derived extracellular vesicles recapitulate the beneficial effects of their parent cells in the treatment of chronic heart failure","volume":"35","author":"Kervadec","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"2022102611022185300_ehz787-B51","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.scr.2009.05.004","article-title":"Improvement of mouse cardiac function by hESC-derived cardiomyocytes correlates with vascularity but not graft size","volume":"3","author":"van Laake","year":"2009","journal-title":"Stem Cell Res"},{"key":"2022102611022185300_ehz787-B52","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/CIRCRESAHA.108.175505","article-title":"Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents","volume":"102","author":"van Laake","year":"2008","journal-title":"Circ Res"},{"key":"2022102611022185300_ehz787-B53","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00018-009-0179-z","article-title":"Extracellular matrix formation after transplantation of human embryonic stem cell-derived cardiomyocytes","volume":"67","author":"van Laake","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"2022102611022185300_ehz787-B54","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nbt1327","article-title":"Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts","volume":"25","author":"Laflamme","year":"2007","journal-title":"Nat Biotechnol"},{"key":"2022102611022185300_ehz787-B55","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.jacc.2007.07.054","article-title":"Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts","volume":"50","author":"Caspi","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2022102611022185300_ehz787-B56","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/CIRCRESAHA.114.304616","article-title":"Embryonic stem cell-derived cardiac myocytes are not ready for human trials","volume":"115","author":"Anderson","year":"2014","journal-title":"Circ Res"},{"key":"2022102611022185300_ehz787-B57","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.molmed.2013.01.004","article-title":"Mutation rate in stem cells: an underestimated barrier on the way to therapy","volume":"19","author":"Sverdlov","year":"2013","journal-title":"Trends Mol Med"},{"key":"2022102611022185300_ehz787-B58","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.cell.2005.08.020","article-title":"Core transcriptional regulatory circuitry in human embryonic stem cells","volume":"122","author":"Boyer","year":"2005","journal-title":"Cell"},{"key":"2022102611022185300_ehz787-B59","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1242\/dev.102624","article-title":"Transcription factor heterogeneity in pluripotent stem cells: a stochastic advantage","volume":"141","author":"Torres-Padilla","year":"2014","journal-title":"Development"},{"key":"2022102611022185300_ehz787-B60","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.cell.2011.01.032","article-title":"Control of the embryonic stem cell state","volume":"144","author":"Young","year":"2011","journal-title":"Cell"},{"key":"2022102611022185300_ehz787-B61","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17121982","article-title":"Emerging non-canonical functions and regulation by p53: p53 and stemness","volume":"17","author":"Olivos","year":"2016","journal-title":"Int J Mol Sci"},{"key":"2022102611022185300_ehz787-B62","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1158\/0008-5472.CAN-18-0805","article-title":"A mutant p53-dependent embryonic stem cell gene signature is associated with augmented tumorigenesis of stem cells","volume":"78","author":"Koifman","year":"2018","journal-title":"Cancer Res"},{"key":"2022102611022185300_ehz787-B63","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.tcm.2007.02.003","article-title":"Bypassing heterogeneity: the road to embryonic stem cell-derived cardiomyocyte specification","volume":"17","author":"Singh","year":"2007","journal-title":"Trends Cardiovasc Med"},{"key":"2022102611022185300_ehz787-B64","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"2022102611022185300_ehz787-B65","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature08180","article-title":"Elite and stochastic models for induced pluripotent stem cell generation","volume":"460","author":"Yamanaka","year":"2009","journal-title":"Nature"},{"key":"2022102611022185300_ehz787-B66","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.stem.2009.06.008","article-title":"Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures","volume":"5","author":"Chin","year":"2009","journal-title":"Cell Stem Cell"},{"key":"2022102611022185300_ehz787-B67","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature09017","article-title":"Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells","volume":"465","author":"Stadtfeld","year":"2010","journal-title":"Nature"},{"key":"2022102611022185300_ehz787-B68","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.stem.2010.06.015","article-title":"Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells","volume":"7","author":"Guenther","year":"2010","journal-title":"Cell Stem Cell"},{"key":"2022102611022185300_ehz787-B69","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.stem.2010.06.016","article-title":"Lab-specific gene expression signatures in pluripotent stem cells","volume":"7","author":"Newman","year":"2010","journal-title":"Cell Stem Cell"},{"key":"2022102611022185300_ehz787-B70","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1161\/CIRCULATIONAHA.108.778795","article-title":"Generation of functional murine cardiac myocytes from induced pluripotent stem cells","volume":"118","author":"Mauritz","year":"2008","journal-title":"Circulation"},{"key":"2022102611022185300_ehz787-B71","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1096\/fj.08-128546","article-title":"Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro","volume":"23","author":"Kuzmenkin","year":"2009","journal-title":"FASEB J"},{"key":"2022102611022185300_ehz787-B72","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/cvr\/cvq189","article-title":"Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice","volume":"88","author":"Kaichi","year":"2010","journal-title":"Cardiovasc Res"},{"key":"2022102611022185300_ehz787-B73","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12265-009-9150-5","article-title":"c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells","volume":"3","author":"Martinez-Fernandez","year":"2010","journal-title":"J Cardiovasc Transl Res"},{"key":"2022102611022185300_ehz787-B74","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.stem.2008.01.001","article-title":"The emergence of hematopoietic stem cells is initiated in the placental vasculature in the absence of circulation","volume":"2","author":"Rhodes","year":"2008","journal-title":"Cell Stem Cell"},{"key":"2022102611022185300_ehz787-B75","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1161\/CIRCRESAHA.108.192237","article-title":"Functional cardiomyocytes derived from human induced pluripotent stem cells","volume":"104","author":"Zhang","year":"2009","journal-title":"Circ Res"},{"key":"2022102611022185300_ehz787-B76","doi-asserted-by":"crossref","first-page":"98.","DOI":"10.1186\/1471-213X-10-98","article-title":"Global transcriptional profiles of beating clusters derived from human induced pluripotent stem cells and embryonic stem cells are highly similar","volume":"10","author":"Gupta","year":"2010","journal-title":"BMC Dev Biol"},{"key":"2022102611022185300_ehz787-B77","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1634\/stemcells.2008-0033","article-title":"Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages","volume":"26","author":"Schenke-Layland","year":"2008","journal-title":"Stem Cells"},{"key":"2022102611022185300_ehz787-B78","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-1-62703-348-0_12","article-title":"Highly efficient directed differentiation of human induced pluripotent stem cells into cardiomyocytes","volume":"997","author":"Burridge","year":"2013","journal-title":"Methods Mol Biol"},{"key":"2022102611022185300_ehz787-B79","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.1162494","article-title":"Induced pluripotent stem cells generated without viral integration","volume":"322","author":"Stadtfeld","year":"2008","journal-title":"Science"},{"key":"2022102611022185300_ehz787-B80","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1172482","article-title":"Human induced pluripotent stem cells free of vector and transgene sequences","volume":"324","author":"Yu","year":"2009","journal-title":"Science"},{"key":"2022102611022185300_ehz787-B81","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1164270","article-title":"Generation of mouse induced pluripotent stem cells without viral vectors","volume":"322","author":"Okita","year":"2008","journal-title":"Science"},{"key":"2022102611022185300_ehz787-B82","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.stem.2009.04.005","article-title":"Generation of induced pluripotent stem cells using recombinant proteins","volume":"4","author":"Zhou","year":"2009","journal-title":"Cell Stem Cell"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/41\/25\/2397\/46643011\/eurheartj_41_25_2397.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/41\/25\/2397\/46643011\/eurheartj_41_25_2397.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T11:10:20Z","timestamp":1666782620000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/41\/25\/2397\/5645359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,28]]},"references-count":82,"journal-issue":{"issue":"25","published-online":{"date-parts":[[2019,11,28]]},"published-print":{"date-parts":[[2020,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehz787","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,7,1]]},"published":{"date-parts":[[2019,11,28]]}}}